In conclusion, we demonstrated for the first time in this study that a high density of FcγRIIIa+ (CD16) intraepithelial TAN in close contact with tumor cells in CRC metastases, is associated with an improved response to cetuximab. The gene discussed is FCGR3A; the disease is neoplasm.